phenylethyl alcohol has been researched along with Refractory Depression in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkinson, S; Ball, SG; Bangs, M; Dubé, S; Goldberger, C; Sparks, J | 1 |
| Fava, M; Goldberger, C; Gorwood, P; Liu, P; Marangell, LB; Nelson, C; Stauffer, VL | 1 |
1 trial(s) available for phenylethyl alcohol and Refractory Depression
| Article | Year |
|---|---|
Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.
Topics: Adjuvants, Pharmaceutic; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Phenylethyl Alcohol; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 2015 |
1 other study(ies) available for phenylethyl alcohol and Refractory Depression
| Article | Year |
|---|---|
Is the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder?
Topics: Adrenergic Uptake Inhibitors; Adult; Clinical Trials as Topic; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Humans; Morpholines; Norepinephrine; Phenylethyl Alcohol; Prognosis; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors | 2017 |